Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
作者更正:4-1BB共刺激CD19特异性CAR-NK细胞疗法治疗难治性/复发性大B细胞淋巴瘤的安全性和可行性:一项I期试验
期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-025-01026-w
Lei, Wen; Liu, Hui; Deng, Wenhai; Chen, Wei; Liang, Yun; Gao, Wenxia; Yuan, Xianggui; Guo, Shanshan; Li, Ping; Wang, Jinyong; Tong, Xiangmin; Sun, Yi Eve; Liang, Aibin; Qian, Wenbin
免疫/内分泌
B细胞
CD19
淋巴瘤
细胞生物学
CAR-NK